Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
BEAM
Stock Latest News
Market News
Cathie Wood Starts This Volatile Week with $13M Buy and a Key Sell-Off
10d ago
BEAM
RBLX
Premium
The Fly
Cathie Wood’s ARK Investment buys 659K shares of Beam Therapeutics today
11d ago
BEAM
Premium
Market News
Cathie Wood Marks Independence Day with Strategic Buys and a Major Sell-Off
14d ago
ARKG
ARKK
Premium
The Fly
Cathie Wood’s ARK Investment buys 29K shares of Beam Therapeutics today
15d ago
BEAM
Premium
Company Announcements
Beam Therapeutics Acquires Early-Stage Life Sciences Firm
15d ago
8K
BEAM
Premium
The Fly
Cathie Wood’s ARK Investment buys 55K shares of Beam Therapeutics today
16d ago
BEAM
Premium
Ratings
Beam Therapeutics: Advancements in Gene Editing and Promising Clinical Milestones Justify Buy Rating
18d ago
BEAM
Premium
Market News
3 Best Stocks to Buy Now, 6/26/2025, According to Top Analysts
22d ago
LLY
BBIO
Premium
Ratings
JPMorgan’s Bullish Outlook on Beam Therapeutics: Promising Genetic Base-Editing Platform and Strategic Growth Prospects
23d ago
BEAM
Premium
Ratings
Beam Therapeutics Receives Buy Rating on Promising Sickle Cell Therapy Data and Market Potential
1M ago
BEAM
Premium
Ratings
Bullish Outlook on Beam Therapeutics Driven by Promising Clinical Data and Market Opportunities
1M ago
BEAM
Premium
Ratings
Positive Outlook for Beam Therapeutics’ BEAM-101 in Sickle Cell Disease Treatment Justifies Buy Rating
1M ago
BEAM
Premium
Ratings
Beam Therapeutics’ BEAM-101 Shows Promising Results in Sickle Cell Disease, Justifying Buy Rating
1M ago
BEAM
Premium
Ratings
Beam Therapeutics’ BEAM-101: Promising Advancements in Sickle Cell Disease Treatment with Strong Phase 1/2 Trial Results
1M ago
BEAM
Premium
The Fly
Beam Therapeutics announces new data from BEACON Phase 1/2 trial
1M ago
BEAM
Premium
The Fly
Cathie Wood’s ARK Investment buys 349K shares of Beam Therapeutics today
1M ago
BEAM
Premium
Company Announcements
Beam Therapeutics Confirms Key Decisions at Annual Meeting
1M ago
8K
BEAM
Premium
The Fly
Beam Therapeutics announces U.S. FDA granted ODD to BEAM-101
2M ago
BEAM
Premium
The Fly
Beam Therapeutics treatment of sickle cell disease granted orphan designation
2M ago
BEAM
Premium
The Fly
Beam Therapeutics receives orphan drug designation for BEAM-302
2M ago
BEAM
Premium
The Fly
Beam Therapeutics treatment of alpha-1 antitrypsin deficiency gets orphan status
2M ago
BEAM
Premium
The Fly
Beam Therapeutics announces FDA grants RMAT designation to BEAM-302
2M ago
BEAM
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
